Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), a vertically integrated multistate operator and the No. 1 U.S. wholesaler of branded cannabis products, today announced the expansion of its Sunnyside retail brand in Florida with three new dispensaries in Cape Coral, Tampa and Panama City Beach, Florida. These additional stores bring Cresco’s store network to 19 locations in Florida and 53 total in the U.S.
Cresco Labs has opened three new Florida stores, bringing its Sunnyside network to 19 locations in the state and 53 total nationwide. (Photo: Business Wire)
“We are thrilled to bring Cresco Labs’ portfolio of leading cannabis brands to patients in Cape Coral, Tampa and Panama City Beach,” said Charlie Bachtell, Co-Founder and CEO of Cresco Labs. “When patients have the opportunity to visit our stores and try our category leaders such as High Supply flower and vapes and Sunnyside Chews edibles, they understand why we are the No. 1 wholesaler of branded cannabis products in the U.S. per BDSA. With nearly 750,000 qualified patients, over $2 billion in market revenue (per BDSA) and adult-use still on the horizon, Florida remains an attractive growth opportunity. We have several additional locations planned for the fourth quarter of 2022 and early 2023, which, combined with Columbia Care’s retail footprint, will help us reach our goal of becoming one of the leading operators in the state.”
Sunnyside Cape Coral is the Company’s first dispensary in North Lee County. It resides near a Walmart Supercenter and Publix and is a half mile from city thoroughfare Veterans Parkway.
Sunnyside Tampa is in the heart of the city’s primary retail corridor across from Walmart and Best Buy and just five minutes to Raymond James Stadium. It also is accessibly located just off the I-275.
Sunnyside Panama City Beach will be opening in a few weeks located a few blocks from scenic Hwy 30A, which is easily accessible to locals, commuters and guests of numerous beachside resorts.
